Form D — DSIpharma, Inc.
0002076369-25-000001 · filed 2025-07-15
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $500,000
- Total sold
- $45,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- DSIpharma, Inc.
- CIK
- 2076369
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808 - Phone
- 866-403-5272
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark Ridall · Executive OfficerWilmington, DE Find on LinkedIn ↗
-
Kysha Ayana Pierre-Louis · Executive OfficerWilmington, DE Find on LinkedIn ↗
View original on SEC EDGAR.